CoChat

Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis

Open access
Willemsen, M. A., Verbeek, M. M., Kamsteeg, E.-J., de Rijk-van Andel, J. F., Aeby, A., Blau, N., Burlina, A., Donati, M. A., Geurtz, B., Grattan-Smith, P. J., Haeussler, M., Hoffmann, G. F., Jung, H., de Klerk, J. B., van der Knaap, M. S., Kok, F., Leuzzi, V., de Lonlay, P., Megarbane, A., Monaghan, H., Renier, W. O., Rondot, P., Ryan, M. M., Seeger, J., Smeitink, J. A., Steenbergen-Spanjers, G. C., Wassmer, E., Weschke, B., Wijburg, F. A., Wilcken, B., Zafeiriou, D. I., Wevers, R. A. · 2010 · Brain
Cited by 236

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Tyrosine hydroxylase deficiency is an autosomal recessive disorder resulting from cerebral catecholamine deficiency. Tyrosine hydroxylase deficiency has been reported in fewer than 40 patients worldwide. To recapitulate all available evidence on clinical phenotypes and rational diagnostic and therapeutic approaches for this devastating, but treatable, neurometabolic disorder, we studied 36 patients with tyrosine hydroxylase deficiency and reviewed the literature. Based on the presenting neurological features, tyrosine hydroxylase deficiency can be divided in two phenotypes: an infantile onset, progressive, hypokinetic-rigid syndrome with dystonia (type A), and a complex encephalopathy with neonatal onset (type B). Decreased cerebrospinal fluid concentrations of homovanillic acid and 3-methoxy-4-hydroxyphenylethylene glycol, with normal 5-hydroxyindoleacetic acid cerebrospinal fluid concentrations, are the biochemical hallmark of tyrosine hydroxylase deficiency. The homovanillic acid concentrations and homovanillic acid/5-hydroxyindoleacetic acid ratio in cerebrospinal fluid correlate with the severity of the phenotype. Tyrosine hydroxylase deficiency is almost exclusively caused by missense mutations in the TH gene and its promoter region, suggesting that mutations with more deleterious effects on the protein are incompatible with life. Genotype-phenotype correlations do not exist for the common c.698G>A and c.707T>C mutations. Carriership of at least one promotor mutation, however, apparently predicts type A tyrosine hydroxylase deficiency. Most patients with tyrosine hydroxylase deficiency can be successfully treated with l-dopa.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awq087

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 236

Metadata

Authors
Willemsen, M. A., Verbeek, M. M., Kamsteeg, E.-J., de Rijk-van Andel, J. F., Aeby, A., Blau, N., Burlina, A., Donati, M. A., Geurtz, B., Grattan-Smith, P. J., Haeussler, M., Hoffmann, G. F., Jung, H., de Klerk, J. B., van der Knaap, M. S., Kok, F., Leuzzi, V., de Lonlay, P., Megarbane, A., Monaghan, H., Renier, W. O., Rondot, P., Ryan, M. M., Seeger, J., Smeitink, J. A., Steenbergen-Spanjers, G. C., Wassmer, E., Weschke, B., Wijburg, F. A., Wilcken, B., Zafeiriou, D. I., & Wevers, R. A.
Venue
Brain
Published
2010-04-29
Volume
133
Issue
6
Pages
1810-1822
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2135688455
Cited by
236
References
1
FWCI
5.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. https://app.cochat.ai/papers/10.1093/brain/awq087
The paper
Willemsen, M. A., Verbeek, M. M., Kamsteeg, E.-J., de Rijk-van Andel, J. F., Aeby, A., Blau, N., Burlina, A., Donati, M. A., Geurtz, B., Grattan-Smith, P. J., Haeussler, M., Hoffmann, G. F., Jung, H., de Klerk, J. B., van der Knaap, M. S., Kok, F., Leuzzi, V., de Lonlay, P., Megarbane, A., . . . Wevers, R. A. (2010). Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain. https://doi.org/10.1093/brain/awq087

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.